UNLIMITED TURBO LONG - ABBOTT LABORATORIES Share Price

Certificat

DE000PF50CN6

Delayed Deutsche Boerse AG 12:50:38 26/06/2024 BST
3.05 EUR +0.66% Intraday chart for UNLIMITED TURBO LONG - ABBOTT LABORATORIES
Current month+12.22%
1 month+3.77%
Date Price Change
26/06/24 3.05 +0.66%
25/06/24 3.03 +0.33%
24/06/24 3.02 -1.95%
21/06/24 3.08 -2.53%
20/06/24 3.16 +9.34%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 12:50 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF50CN
ISINDE000PF50CN6
Date issued 15/01/2021
Strike 73.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.39
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 7.14
Lowest since issue 2.04
Spread 0.03
Spread %0.98%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
105.5 USD
Average target price
125.2 USD
Spread / Average Target
+18.64%
Consensus